organophosphonates has been researched along with Autoimmune Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lampertico, P; Mangia, G; Viganò, M | 1 |
| Morvai, K; Rácz, T; Szegedi, G; Szekanecz, E; Szekanecz, Z; Sziklai, I | 1 |
2 review(s) available for organophosphonates and Autoimmune Disease
| Article | Year |
|---|---|
Management of patients with overt or resolved hepatitis B virus infection undergoing rituximab therapy.
Topics: Adenine; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Carrier State; Disease Management; DNA, Viral; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Organophosphonates; Rituximab; Tenofovir; Virus Activation | 2014 |
[Current aspects of the pathogenesis and clinical characteristics of otosclerosis: possibilities of drug therapy].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Diseases; Calcitonin; Deafness; Flavonoids; Fluorides; Humans; Morbillivirus Infections; Organophosphonates; Osteoporosis; Otosclerosis; Vitamin D | 1999 |